Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019

SELL
$132.75 - $203.8 $90,270 - $138,584
-680 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$147.44 - $204.11 $28,013 - $38,780
190 Added 38.78%
680 $139,000
Q2 2018

Aug 10, 2018

SELL
$144.9 - $165.58 $14.4 Million - $16.5 Million
-99,647 Reduced 99.51%
490 $72,000
Q1 2018

May 21, 2018

BUY
$131.46 - $151.04 $13.1 Million - $15 Million
99,391 Added 13323.19%
100,137 $100,000
Q4 2017

Feb 14, 2018

BUY
$121.17 - $134.75 $90,392 - $100,523
746
746 $104,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.87B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.